Quest Diagnostics Incorporated
DGX
Classifica tra le azioni
#934
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Prezzo delle azioni
$234.71
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$25.91B
Variazione (1 giorno)
-1.76%
Variazione (1 anno)
23.85%
Paese
US
Scambia Quest Diagnostics Incorporated (DGX)
Categoria
Healthcare
EPS per Quest Diagnostics Incorporated (DGX)
EPS al June 2026 TTM: $9.54
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Quest Diagnostics Incorporated, l’EPS attuale della società (TTM) è $9.54. Alla fine del 2024, la società aveva un EPS di $7.80 un aumento rispetto a rispetto a quello del 2023, che era di $7.59.
Storico EPS per Quest Diagnostics Incorporated da 2000 a 2026
EPS alla fine di ogni anno
| Anno | EPS | Cambia |
|---|---|---|
| 2026 (TTM) | $9.54 | 7.55% |
| 2025 | $8.87 | 13.72% |
| 2024 | $7.80 | 2.77% |
| 2023 | $7.59 | -6.53% |
| 2022 | $8.12 | -48.93% |
| 2021 | $15.90 | 48.88% |
| 2020 | $10.68 | 67.40% |
| 2019 | $6.38 | 17.93% |
| 2018 | $5.41 | -3.91% |
| 2017 | $5.63 | 22.93% |
| 2016 | $4.58 | -6.91% |
| 2015 | $4.92 | 28.46% |
| 2014 | $3.83 | -31.36% |
| 2013 | $5.58 | 59.89% |
| 2012 | $3.49 | 18.31% |
| 2011 | $2.95 | -27.70% |
| 2010 | $4.08 | 4.35% |
| 2009 | $3.91 | 30.77% |
| 2008 | $2.99 | 69.89% |
| 2007 | $1.76 | -40.94% |
| 2006 | $2.98 | 9.96% |
| 2005 | $2.71 | 10.61% |
| 2004 | $2.45 | 16.11% |
| 2003 | $2.11 | 26.35% |
| 2002 | $1.67 | 91.95% |
| 2001 | $0.87 | 52.63% |
| 2000 | $0.57 | 0.00% |
EPS per aziende simili o concorrenti
| Azienda | EPS | Differenza di EPS | Il paese |
|---|---|---|---|
| $18.62 | 95.18% |
US
|
|
| $5.65 | -40.78% |
US
|
|
| $-1.36 | -114.26% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -46.65% |
US
|
